Yahoo · Nov 5, 2026
4 Healthcare ETFs to Tap Into Eli Lilly's Post-Q3 Earnings Rally
Eli Lilly's post-Q3 earnings rally highlights its surging drug demand. Discover 4 healthcare ETFs offering LLY exposure.
NYSE · VHT
Financial Services · Asset Management
$334.34
Down-$5.50 (-1.65%)
Updated Nov 19, 2026, 3:45 PM
SID Score
6.8/10
Composite research score
Smart Money
54/100
Neutral
Price performance · VHT
1M range · 21 trading sessions · Daily adjusted prices
Prices through Nov 18, 2026
VHT closed at $334.34 after 21 trading sessions, up 0.63% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Nov 18, 2026 | $338.445 | $341.24 | $333.59 | $334.34 | 330.27K |
| Nov 17, 2026 | $342.46 | $344.16 | $339.63 | $341.07 | 234.48K |
| Nov 16, 2026 | $350.49 | $352.0248 | $345.05 | $345.56 | 212.91K |
| Nov 13, 2026 | $347.67 | $348.58 | $345.00 | $347.93 | 159.76K |
| Nov 12, 2026 | $350.83 | $351.52 | $346.41 | $346.45 | 161.8K |
| Nov 11, 2026 | $346.83 | $349.85 | $345.735 | $349.35 | 235.76K |
| Nov 10, 2026 | $347.62 | $349.45 | $344.865 | $348.81 | 191.3K |
| Nov 9, 2026 | $344.545 | $349.2275 | $342.29 | $348.11 | 276.62K |
| Nov 6, 2026 | $335.79 | $343.0793 | $334.76 | $341.23 | 546.17K |
| Nov 5, 2026 | $353.68 | $354.83 | $341.07 | $341.20 | 549.63K |
| Nov 4, 2026 | $347.28 | $352.12 | $343.01 | $351.23 | 496.62K |
| Nov 3, 2026 | $339.99 | $343.8299 | $339.99 | $340.80 | 388.81K |
| Nov 2, 2026 | $342.605 | $343.88 | $339.42 | $341.27 | 392.48K |
| Oct 30, 2026 | $345.60 | $348.26 | $341.77 | $342.33 | 563.05K |
| Oct 29, 2026 | $339.77 | $343.58 | $338.275 | $341.93 | 347.62K |
| Oct 28, 2026 | $329.65 | $337.04 | $329.65 | $334.46 | 120.27K |
| Oct 27, 2026 | $331.335 | $333.83 | $330.4603 | $333.16 | 138.3K |
| Oct 26, 2026 | $333.25 | $335.8704 | $331.32 | $332.71 | 174.76K |
| Oct 23, 2026 | $334.36 | $335.35 | $331.43 | $332.53 | 227.82K |
| Oct 22, 2026 | $333.32 | $337.615 | $332.52 | $336.26 | 164.77K |
| Oct 21, 2026 | $331.10 | $334.16 | $330.45 | $332.24 | 192.86K |
The latest Smart Investors Daily articles mentioning VHT.
Company
Market Activity
Research & News
VHT research
Company profile and research snapshot.
The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.
Consensus and target data currently published for this company.
No generated briefing is available yet.
Yahoo · Nov 5, 2026
Eli Lilly's post-Q3 earnings rally highlights its surging drug demand. Discover 4 healthcare ETFs offering LLY exposure.
Yahoo · Nov 4, 2026
CVS just announced a plan to split into two separate public companies, and if you own a healthcare ETF, a dividend fund, or an S&P 500 index fund, your portfolio is already caught in the middle of what happens next.
Yahoo · Oct 21, 2026
Sector ETF report for VHT
Yahoo · Oct 20, 2026
Johnson & Johnson's Q3 earnings beat fails to prevent a 6% stock drop, but three healthcare ETFs offer diversified exposure to its growth potential.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning VHT.